London Daily

Focus on the big picture.
Saturday, May 31, 2025

STUDY: Over 95% of Britons develop antibodies after 1 dose of vaccine

STUDY: Over 95% of Britons develop antibodies after 1 dose of vaccine

As a considerable number of residents refuse to take the COVID-19 vaccine locally, a recent UK study has found that more than 95 percent of Britons develop COVID antibodies after taking one dose of the AstraZeneca or Pfizer vaccines.

Antibodies are protective proteins produced by the immune system in response to the presence of a foreign substance called an antigen.

The aforesaid study was conducted by University College London and its findings are based on 8,517 participants across England and Wales.

A compelling 96.42 percent of people who took either of the vaccines developed antibodies 28 to 34 days after their first dose, the study found. The findings further revealed that the number of people producing antibodies rose to 99.08% within seven to 14 days of the second jab.

None of the participants had antibodies before getting vaccinated.

“This is one of the earliest real-world vaccine studies in the UK and it is fantastic news”, said Dr Maddie Shrotri, the lead author of the paper containing the findings.

He added: “Over nine out of 10 adults in the UK who had either the Pfizer or AstraZeneca vaccine produced antibodies against the virus within a month of their first shot … How well these vaccines work is remarkable, especially given the speed at which they’ve been developed. It’s a real feat of science in the face of the most devastating pandemic in a century.”

Other findings


Meanwhile, other findings from the study indicate that one dose of either vaccine stimulated the production of fewer antibodies in older people. However, that changed after the second dose with all ages achieving high antibody levels.

Researchers further found that antibody levels after one dose were also weaker in persons taking immune system suppressing medication and in persons with underlying health conditions such as diabetes, cancer, heart disease. This, however, disappeared once all participants had their second dose.

What’s happening locally


Back on the local scene, the government continues to encourage residents to voluntarily vaccinate as the territory now has 33 active cases.

“The borders are being opened and there will be additional positive cases that will emerge. Unless proven otherwise, the most effective way in protecting the population from the full effects of the COVID-19 virus is by being fully vaccinated,” Health Minister Carvin Malone said in update Tuesday afternoon.

He continued: “Vaccination centres are opened throughout the territory. An additional 5,646 persons can be vaccinated NOW with their first dose. Registration forms will be readily available for everyone.”

Newsletter

Related Articles

0:00
0:00
Close
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
White House Press Secretary Criticizes Harvard Funding, Advocates for Vocational Training
France to Implement Nationwide Smoking Ban in Outdoor Spaces Frequented by Children
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
U.S. Justice Department Reduces American Bar Association's Role in Judicial Nominations
U.S. Department of Energy Unveils 'Doudna' Supercomputer to Advance AI Research
U.S. SEC Dismisses Lawsuit Against Binance Amid Regulatory Shift
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
Italy Faces Population Decline Amid Youth Emigration
U.S. Goods Imports Plunge Nearly 20% Amid Tariff Disruptions
OpenAI Faces Competition from Cheaper AI Rivals
Foreign Tax Provision in U.S. Budget Bill Alarms Investors
Trump Accuses China of Violating Trade Agreement
Gerry Adams Wins Libel Case Against BBC
Russia Accuses Serbia of Supplying Arms to Ukraine
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
Chinese Woman Dies After Being Forced to Visit Bank Despite Critical Illness
President Trump Grants Full Pardons to Reality TV Stars Todd and Julie Chrisley
Texas Enacts App Store Accountability Act Mandating Age Verification
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Vatican Calls for Sustainable Tourism in 2025 Message
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
Trump Threatens 25% Tariff on iPhones Amid Dispute with Apple CEO
Putin's Helicopter Reportedly Targeted by Ukrainian Drones
Liverpool Car Ramming Incident Leaves Multiple Injured
Australia Faces Immigration Debate Following Labor Party Victory
Iranian Revolutionary Guard Founder Warns Against Trusting Regime in Nuclear Talks
Macron Dismisses Viral Video of Wife's Gesture as Playful Banter
Cleveland Clinic Study Questions Effectiveness of Recent Flu Vaccine
Netanyahu Accuses Starmer of Siding with Hamas
Junior Doctors Threaten Strike Over 4% Pay Offer
Labour MPs Urge Chancellor to Tax Wealthy Over Cutting Welfare
Publication of UK Child Poverty Strategy Delayed Until Autumn
France Detains UK Fishing Vessel Amid Post-Brexit Tensions
Calls Grow to Resume Syrian Asylum Claims in UK
Nigel Farage Pledges to Reinstate Winter Fuel Payments
Boris and Carrie Johnson Welcome Daughter Poppy
×